PSUN347 A Novel Mechanism-based Inhibitor of Ribonucleotide Reductase is Highly Effective in Preclinical Models of Endocrine Therapy-Resistant Breast Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.